Tag:

Singapore

Latest Headlines

Latest Headlines

GSK doubles down on Singapore continuous processing plant

Several years ago, GlaxoSmithKline committed $50 million to set up an antibiotics facility in Singapore to do continuous processing, a radically different manufacturing approach that has a much smaller footprint, and so much lower operating costs and less environmental impact, than traditional batch processing. The drugmaker now says it is ready to embark on a £38 million expansion there.

Singapore's Temasek leads $40M financing for sleep monitoring startup Hello

Singapore's state investment company just led an ongoing $40 million financing round supporting Hello, maker of the Sense sleep monitor, demonstrating growing interest in health and fitness-related gadgets among investors, if not the general public.

Singapore clinical group sees gene sequencing key in liver cancer treatment study

A Singapore-led clinical group has published a study of a novel approach to investigating how genes affect options to treat liver cancer, highlighting the city-state's growing role in oncology research.

Singapore clinical hub to work with Visterra on dengue candidate

Singapore's research agency and Duke-National University of Singapore have signed an agreement to collaborate with U.S. biotech Visterra on getting a promising treatment against dengue fever to the clinical-trial stage.

Singapore moving to meet pharma manufacturing demand for high-quality water

Singapore, like other Asian countries looking to woo pharmaceutical manufacturers, is moving quickly to meet increasing demand for high-quality water required by strict regulations in the U.S. and European Union.

Strides spans Singapore, Australia, India and Africa in Aspen generics deal

In a deal spanning three continents, Asia's Strides Arcolab is paying nearly $300 million for the Australian generics business of Africa's Aspen Pharmacare Holdings. The deal also includes some branded drugs.

Indonesia's Kalbe eyes Singapore, Thailand with ASEAN trade bloc ahead

Indonesia's Kalbe Farma is making this year an expansion year as it moves beyond its shores and into Singapore and Thailand and their over-the-counter drug markets as a regional trade pact looks set to start at the end of the year. It also has corporate eyes set on even more countries, with a focus on West Africa.

Singapore's Temasek invests in Sun Pharmaceutical

Singapore government-controlled investment group Temasek has invested more than half a million dollars in Ranbaxy buyer Sun Pharmaceutical as well as other Indian drugmakers.

From the pharma C-suite: Notable, quotable remarks on Asia, emerging markets for Q1 (Part 2)

FiercePharmaAsia  combs earnings calls by major drug companies for notable and quotable nuggets on emerging markets and Asia to track the latest sales trends and insight into business outlooks in markets as diverse as China, India and Japan to Southeast Asia.

Western firms form band of brothers, but welcome others, in Asian medical device association

Major Western device and medical technology firms launched Asia Pacific Medical Technology Association, or APACMed, pledging the association would unite a fragmented effort to work with regulators across a region that is both lucrative and frustrating on issues ranging from import rules to public tender guidelines.